loader2
Login Open ICICI 3-in-1 Account
  • Text Size
  • Text to Speech
  • Color Contrast
  • Pause Animations

Open ICICI
3-in-1 Account

Manage your Savings, Demat and Trading Account conveniently at one place

+91

BLOG

Zydus Lifesciences signed an MoU with Apollo Hospitals

ICICIdirect Research 06 Jul 2026 DISCLAIMER

News: Zydus Lifesciences signed an MoU with Apollo Hospitals to commercialise Guardant Health's Shield Multi-Cancer Detection (MCD) blood test in India. The methylation-based blood test screens for 10 of the most common cancers, including colorectal, lung, breast, prostate and pancreatic cancers, in average-risk individuals aged 45 years and above. The test has received USFDA Breakthrough Device Designation, with the partnership aimed at expanding access to early cancer detection and improving cancer screening in India.

View: This will be Zydus’s maiden foray into diagnostics business with a focus cancer detection. This, being a tripartite agreement, needs further study regarding the scope and economics to determine profitability.

Impact: Neutral

Download ICICI Direct app

Invest, Track, and Manage your Portfolio Anytime, Anywhere

Download ICICI Direct app

Invest, Track, and Manage your Portfolio Anytime, Anywhere